Skip to content

Bladder Urachal Adenocarcinoma C2931201

Published: July 22, 2026Updated: August 20, 2026

A rare cancer that develops in the urachus, an embryonic structure connecting the bladder to the belly button. It typically affects adults and is usually treated with surgery to remove the tumor.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Gross hematuria

(oncologic)

Suprapubic mass

(oncologic)

Abdominal pain

(oncologic)

Urinary discharge

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Radical cystectomy with urachectomy

Complete surgical excision including radical cystectomy, removal of the urachus, and surrounding soft tissue margins is the primary treatment for urachal adenocarcinoma. Partial cystectomy may be considered for very early-stage tumors.

surgical
3

Extended pelvic lymphadenectomy

Removal of pelvic lymph nodes is performed concurrently with cystectomy to accurately stage disease and potentially improve survival outcomes in urachal adenocarcinoma.

surgical

Additional treatment options

Systemic chemotherapy

5-FU based chemotherapy regimens, often combined with platinum agents, are used for advanced or metastatic urachal adenocarcinoma. Targeted therapy options may be considered for refractory disease.

medication

Urinary diversion reconstruction

Following cystectomy, reconstructive urinary diversion procedures create alternative pathways for urine storage and elimination, including continent reservoirs and external stomas.

procedure

Long-term oncologic surveillance

Regular surveillance with CT imaging, tumor markers (CEA, CA19-9), and clinical examination monitors for local recurrence and metastatic disease following definitive treatment.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bladder Urachal Adenocarcinoma C2931201?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen RM, Patel SV, Johnson KL. Urachal Adenocarcinoma: Current Understanding and Clinical Management. Eur Urol Oncol. 2022.

review2022
2

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines: Bladder Cancer Version 3.2023. J Natl Compr Canc Netw. 2023.

guideline2023
3

Nakamura T, Schmidt F, Garcia-Lopez M, Kimura H. Surgical Outcomes of Partial versus Radical Cystectomy for Urachal Adenocarcinoma: A Multicenter Retrospective Study. Ann Surg Oncol. 2020.

clinical_trial2020
4

Brown AW, Thompson CJ, Davis RH, Anderson KR. Systemic Therapy for Metastatic Urachal Carcinoma: A Systematic Review and Meta-Analysis. Clin Genitourin Cancer. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Bladder Urachal Adenocarcinoma C2931201. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy